Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Baxter Rolls Out PerClot Absorbable Hemostatic Powder in U.S. - Medical Product Outsourcing
OEM News

Baxter Rolls Out PerClot Absorbable Hemostatic Powder in U.S.

Marks first passive hemostat for Baxter in the U.S. market.

Baxter rolled out its PerClot passive, absorbable hemostatic powder in the U.S. PerClot was designed for patients with intact coagulation to address mild bleeding, according to the company.
 
“PERCLOT is a strong complement to Baxter’s leading hemostat portfolio,” Steve Wallace, Baxter’s president of Advanced Surgery told the press. “The launch of PERCLOT in the U.S. allows us to provide surgeons with a full range of active and passive hemostatic products for bleeding control, helping to optimize care for their patients.”
 
PerClot polysaccharide granules feature a molecular structure that rapidly absorbs water to create a gelled adhesive matrix, which forms a mechanical barrier to stop further bleeding. The barrier also causes accumulation of platelets, red blood cells, and coagulation proteins (thrombin, fibrinogen, etc.).
 
Clinicians can use PerClot to address a wider variety of intraoperative bleeding, Baxter said, which can help to reduce blood transfusions and major complications, as well as lower the total cost of care. The adjunctive hemostatic device can be used to control bleeding during open and laparoscopic gynecologic, general, cardiovascular, and urology procedures.
 
To date, PerClot is sold in over 35 countries globally after acquiring the product in July 2021.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics